Neurological Surgery

Publications

Found 46 results
Author [ Title(Desc)] Type Year
Filters: Author is Ramakrishna, Rohan  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Ramakrishna R, Raza SM, Kupferman M, Hanna E, DeMonte F.  2016.  Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach.. J Neurosurg. 124(1):115-21.
Moussazadeh N, Tsiouris AJ, Ramakrishna R.  2016.  Advanced Imaging for Biopsy Guidance in Primary Brain Tumors.. Cureus. 8(2):e504.
Bander ED, Magge R, Ramakrishna R.  2018.  Advances in Glioblastoma Operative Techniques.. World Neurosurg. 116:529-538.
Mann J, Ramakrishna R, Magge R, A Wernicke G.  2017.  Advances in Radiotherapy for Glioblastoma.. Front Neurol. 8:748.
Guadix SW, Tao AJ, An A, Demetres M, Tosi U, Chidambaram S, Knisely JPS, Ramakrishna R, Pannullo SC.  2021.  Assessing the long-term safety and efficacy of gamma knife and linear accelerator radiosurgery for vestibular schwannoma: A systematic review and meta-analysis.. Neurooncol Pract. 8(6):639-651.
B
Bander ED, Sherman JH, Bettegowda C, Aghi MK, Sheehan J, Ramakrishna R.  2021.  Beyond guidelines: analysis of current practice patterns of AANS/CNS tumor neurosurgeons.. J Neurooncol. 151(3):361-366.
C
Morgenstern P, Pisapia D, Ramakrishna R.  2017.  Calvarial Plasmacytoma Mimicking Meningioma as the Initial Presentation of Multiple Myeloma.. Cureus. 9(3):e1126.
A Wernicke G, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R et al..  2017.  Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.. J Neurosurg. 126(4):1212-1219.
Noch EK, Ramakrishna R, Magge R.  2018.  Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance.. World Neurosurg. 116:505-517.
A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al..  2017.  Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.
D
Salama GR, Heier LA, Patel P, Ramakrishna R, Magge R, Tsiouris AJohn.  2017.  Diffusion Weighted/Tensor Imaging, Functional MRI and Perfusion Weighted Imaging in Glioblastoma-Foundations and Future.. Front Neurol. 8:660.
Ivanidze J, Roytman M, Skafida M, Kim S, Glynn S, Osborne JR, Pannullo SC, Nehmeh S, Ramakrishna R, Schwartz TH et al..  2022.  Dynamic 68Ga-DOTATATE PET/MRI in the Diagnosis and Management of Intracranial Meningiomas.. Radiol Imaging Cancer. 4(2):e210067.
Chidambaram S, Pannullo SC, Roytman M, Pisapia DJ, Liechty B, Magge RS, Ramakrishna R, Stieg PE, Schwartz TH, Ivanidze J.  2019.  Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.. Neurosurg Focus. 46(6):E10.
E
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..  2020.  Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Trifiletti DM, Ruiz-Garcia H, Quinones-Hinojosa A, Ramakrishna R, Sheehan JP.  2021.  The evolution of stereotactic radiosurgery in neurosurgical practice.. J Neurooncol. 151(3):451-459.
Garton ALA, Kinslow CJ, Rae AI, Mehta A, Pannullo SC, Magge RS, Ramakrishna R, McKhann GM, Sisti MB, Bruce JN et al..  2020.  Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.. J Neurosurg. :1-11.
G
Ivanidze J, Chang SJung, Haghdel A, Kim JTae, RoyChoudhury A, Wu A, Ramakrishna R, Schwartz TH, Cisse B, Stieg P et al..  2024.  [Ga68] DOTATATE PET/MRI-Guided Radiosurgical Treatment Planning and Response Assessment in Meningiomas.. Neuro Oncol.
Mahase SS, O'Brien DARoth, No D, Roytman M, Skafida ME, Lin E, Karakatsanis NA, Osborne JR, Brandmaier A, Pannullo SC et al..  2021.  [Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas.. Neurooncol Adv. 3(1):vdab012.
Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, Karakatsanis N, Ramakrishna R, Knisely J, Schwartz TH et al..  2019.  Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.. J Neuroimaging. 29(5):650-656.
Zhang S, Chiang GChia-Yi, Knapp JMarion, Zecca CM, He D, Ramakrishna R, Magge RS, Pisapia DJ, Fine HAlan, Tsiouris AJohn et al..  2020.  Grading meningiomas utilizing multiparametric MRI with inclusion of susceptibility weighted imaging and quantitative susceptibility mapping.. J Neuroradiol. 47(4):272-277.
I
Wilcox JA, Ramakrishna R, Magge R.  2018.  Immunotherapy in Glioblastoma.. World Neurosurg. 116:518-528.
Younus I, Gerges M, Schwartz TH, Ramakrishna R.  2020.  Impact of Medicaid insurance on outcomes following endoscopic transsphenoidal pituitary surgery.. J Neurosurg. :1-6.
Pisapia DJ, Magge R, Ramakrishna R.  2017.  Improved Pathologic Diagnosis-Forecasting the Future in Glioblastoma.. Front Neurol. 8:707.
Younus I, Gerges MM, Godil SS, Uribe-Cardenas R, Dobri GA, Ramakrishna R, Schwartz TH.  2019.  Incidence and risk factors associated with reoperation for sellar hematoma following endoscopic transsphenoidal pituitary surgery.. J Neurosurg. :1-7.
Ramakrishna R, Zadeh G, Sheehan JP, Aghi MK.  2020.  Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.. J Neurooncol.